Expedia Group, Inc.

NasdaqGS:EXPE Lagerbericht

Marktkapitalisierung: US$14.8b

Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

Expedia Group Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

Expedia Group wird ein jährliches Wachstum der Erträge und Einnahmen um 22.4% bzw. 7.9% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich grow um 29.1% pro Jahr steigen. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 116.4% betragen.

Wichtige Informationen

17.5%

Wachstumsrate der Gewinne

21.4%

EPS-Wachstumsrate

Hospitality Gewinnwachstum19.6%
Wachstumsrate der Einnahmen6.5%
Zukünftige Eigenkapitalrendite204.3%
Analystenabdeckung

Good

Zuletzt aktualisiert15 May 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Expedia: Adapting To The 'New Normal' For Travel, But Consumer Segment Remains Risky

May 23

Expedia Group Q1: Revenue Performance Encouraging, But VRBO Concern Remains

May 09

Expedia: A Confident Buy Before Earnings

Apr 22

Expedia Group: Travelling Toward Recovery And Breakout From The U.S.

Apr 04

Expedia's Next Phase Of Its Post-Pandemic Transition Holds Promise

Mar 22

Book A Trip To Undervaluation With Expedia Group

Mar 15

Buy Expedia As Technical Strength Emerges

Feb 20

We Think Expedia Group's (NASDAQ:EXPE) Robust Earnings Are Conservative

Feb 16
We Think Expedia Group's (NASDAQ:EXPE) Robust Earnings Are Conservative

Expedia Group: Attractive P/E Ratio And Strong B2B Revenue Growth

Feb 11

Why Expedia Group, Inc. (NASDAQ:EXPE) Could Be Worth Watching

Feb 02
Why Expedia Group, Inc. (NASDAQ:EXPE) Could Be Worth Watching

Expedia Is A Better Buy Than Airbnb

Jan 15

With Expedia Group, Inc. (NASDAQ:EXPE) It Looks Like You'll Get What You Pay For

Jan 02
With Expedia Group, Inc. (NASDAQ:EXPE) It Looks Like You'll Get What You Pay For

Does Expedia Group (NASDAQ:EXPE) Have A Healthy Balance Sheet?

Dec 03
Does Expedia Group (NASDAQ:EXPE) Have A Healthy Balance Sheet?

Here's Why Expedia Group (NASDAQ:EXPE) Has Caught The Eye Of Investors

Nov 17
Here's Why Expedia Group (NASDAQ:EXPE) Has Caught The Eye Of Investors

Is There An Opportunity With Expedia Group, Inc.'s (NASDAQ:EXPE) 48% Undervaluation?

Nov 02
Is There An Opportunity With Expedia Group, Inc.'s (NASDAQ:EXPE) 48% Undervaluation?

Is It Too Late To Consider Buying Expedia Group, Inc. (NASDAQ:EXPE)?

Sep 21
Is It Too Late To Consider Buying Expedia Group, Inc. (NASDAQ:EXPE)?

Here's Why We Think Expedia Group (NASDAQ:EXPE) Is Well Worth Watching

Aug 08
Here's Why We Think Expedia Group (NASDAQ:EXPE) Is Well Worth Watching

Here's Why Expedia Group (NASDAQ:EXPE) Can Manage Its Debt Responsibly

Jul 24
Here's Why Expedia Group (NASDAQ:EXPE) Can Manage Its Debt Responsibly

Expedia Group, Inc. (NASDAQ:EXPE) Shares Could Be 42% Below Their Intrinsic Value Estimate

Jul 08
Expedia Group, Inc. (NASDAQ:EXPE) Shares Could Be 42% Below Their Intrinsic Value Estimate

Should You Think About Buying Expedia Group, Inc. (NASDAQ:EXPE) Now?

Jun 23
Should You Think About Buying Expedia Group, Inc. (NASDAQ:EXPE) Now?

If EPS Growth Is Important To You, Expedia Group (NASDAQ:EXPE) Presents An Opportunity

May 07
If EPS Growth Is Important To You, Expedia Group (NASDAQ:EXPE) Presents An Opportunity

Expedia Group (NASDAQ:EXPE) Has A Pretty Healthy Balance Sheet

Apr 17
Expedia Group (NASDAQ:EXPE) Has A Pretty Healthy Balance Sheet

Is There An Opportunity With Expedia Group, Inc.'s (NASDAQ:EXPE) 45% Undervaluation?

Mar 27
Is There An Opportunity With Expedia Group, Inc.'s (NASDAQ:EXPE) 45% Undervaluation?

Should You Investigate Expedia Group, Inc. (NASDAQ:EXPE) At US$108?

Mar 06
Should You Investigate Expedia Group, Inc. (NASDAQ:EXPE) At US$108?

Does Expedia Group (NASDAQ:EXPE) Have A Healthy Balance Sheet?

Dec 30
Does Expedia Group (NASDAQ:EXPE) Have A Healthy Balance Sheet?

Should You Investigate Expedia Group, Inc. (NASDAQ:EXPE) At US$104?

Dec 04
Should You Investigate Expedia Group, Inc. (NASDAQ:EXPE) At US$104?

Expedia Group names new chief financial officer

Sep 14

Why Expedia Group, Inc. (NASDAQ:EXPE) Could Be Worth Watching

Aug 28
Why Expedia Group, Inc. (NASDAQ:EXPE) Could Be Worth Watching

Expedia Group commences up to $500M tender offer

Aug 26

Expedia: Q2 2019 Vs. Q2 2022 - Something Doesn't Add Up

Aug 07

These 4 Measures Indicate That Expedia Group (NASDAQ:EXPE) Is Using Debt Extensively

Aug 01
These 4 Measures Indicate That Expedia Group (NASDAQ:EXPE) Is Using Debt Extensively

Expedia Stock: Gradual Recovery

Jun 16

Expedia Group (NASDAQ:EXPE) is Navigating Through Conflicting Signals

May 04
Expedia Group (NASDAQ:EXPE) is Navigating Through Conflicting Signals

At US$183, Is Expedia Group, Inc. (NASDAQ:EXPE) Worth Looking At Closely?

Apr 28
At US$183, Is Expedia Group, Inc. (NASDAQ:EXPE) Worth Looking At Closely?

Expedia: U.S. Exposure And Travel Recovery Will Play In Its Favour

Apr 07

Expedia Group, Inc. (NASDAQ:EXPE) Shares Could Be 23% Below Their Intrinsic Value Estimate

Feb 22
Expedia Group, Inc. (NASDAQ:EXPE) Shares Could Be 23% Below Their Intrinsic Value Estimate

Is Expedia Stock A Buy Or Sell After Recent Earnings? Look At What Has Been Priced In

Feb 16

Gewinn- und Umsatzwachstumsprognosen

NasdaqGS:EXPE - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/202615,8071,6272,1043,10318
12/31/202514,8071,4342,3873,09631
12/31/202413,7411,1192,2233,38328
3/31/202413,0638071,6222,412N/A
12/31/202312,8397971,8442,690N/A
9/30/202312,5708421,9002,746N/A
6/30/202312,2608992,3213,124N/A
3/31/202312,0833292,8673,606N/A
12/31/202211,6673522,7783,440N/A
9/30/202211,3284513,2793,907N/A
6/30/202210,6713313,0463,683N/A
3/31/20229,6012153,9084,569N/A
12/31/20218,598-2693,0753,748N/A
9/30/20217,239-9572,4203,078N/A
6/30/20215,781-1,5402,8253,480N/A
3/31/20214,236-1,992-1,558-880N/A
12/31/20205,199-2,687-4,631-3,834N/A
9/30/20207,026-2,199-4,073-3,108N/A
6/30/20209,080-1,569-4,230-3,150N/A
3/31/202011,667-633-1,339-166N/A
12/31/201912,0675651,6072,767N/A
9/30/201911,8795061,1732,281N/A
6/30/201911,5976221,7312,771N/A
3/31/201911,3244401,4882,448N/A
12/31/201811,2234061,0971,975N/A
9/30/201810,9834441,2012,019N/A
6/30/201810,6732711,1831,947N/A
3/31/201810,3793271,0981,833N/A
12/31/201710,060378N/A1,845N/A
9/30/20179,834402N/A1,967N/A
6/30/20179,449330N/A2,227N/A
3/31/20179,059304N/A2,144N/A
12/31/20168,774282N/A1,549N/A
9/30/20168,379190N/A1,370N/A
6/30/20167,736194N/A1,432N/A
3/31/20167,203612N/A1,425N/A
12/31/20156,672764N/A1,368N/A
9/30/20156,330843N/A1,342N/A
6/30/20156,104817N/A1,564N/A
3/31/20155,937457N/A1,447N/A
12/31/20145,763398N/A1,367N/A
9/30/20145,560427N/A1,355N/A
6/30/20145,249341N/A1,042N/A
3/31/20144,959323N/A867N/A
12/31/20134,771233N/A777N/A
9/30/20134,594145N/A772N/A
6/30/20134,391144N/A1,036N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: EXPEDas prognostizierte Gewinnwachstum (22.4% pro Jahr) liegt über der Sparquote (2.2%).

Ertrag vs. Markt: EXPEDie Erträge des Unternehmens (22.4% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (14.9% pro Jahr).

Hohe Wachstumserträge: EXPEDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: EXPEDie Einnahmen des Unternehmens (7.9% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.1% pro Jahr).

Hohe Wachstumseinnahmen: EXPEDie Einnahmen des Unternehmens (7.9% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: EXPEDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich sehr hoch sein (116.4%).

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y